1 min read
Global Compliance vs Local Reality
In today’s pharmaceutical landscape, many companies rely on dossiers aligned with the International Council for Harmonisation to support global regulatory submissions. These frameworks promote consistency in quality, safety, and efficacy standards across multiple markets.
However, compliance with ICH guidelines alone does not ensure approval in every country. In Colombia, regulatory evaluation is conducted by INVIMA, which operates within its own legal and technical framework.
Where Global Dossiers Fall Short
While ICH-based dossiers provide a structured foundation, they may not fully address local regulatory expectations in Colombia. Common gaps include:
- Administrative and format requirements specific to INVIMA
- Product classification nuances that differ from other markets
- Local documentation or adaptations required for submission
- Interpretation differences in technical data and supporting evidence
These gaps do not necessarily reflect deficiencies in the dossier—but rather differences in regulatory context.
Why Localization Matters
Bridging a global dossier to Colombia requires more than translation or formatting adjustments. It involves aligning the dossier with local regulatory logic and ensuring that all components respond to INVIMA’s expectations.
This includes understanding:
- How global data is interpreted locally
- What additional documentation may be required
- How submission strategies should be adapted to local pathways
Without this alignment, even well-prepared global dossiers may face delays, requests for additional information, or extended review timelines.
From Compliance to Readiness
For pharmaceutical companies, the key is shifting from a “global compliance” mindset to a regulatory readiness approach tailored to each market.
In Colombia, this means recognizing that:
- Global standards are a starting point—not the final requirement
- Local regulatory frameworks ultimately determine approval outcomes
- Early identification of gaps can significantly improve efficiency
ICH compliance remains a critical foundation for global regulatory submissions. However, in markets like Colombia, approval depends on how effectively global dossiers are aligned with local regulatory expectations.
Bridging that gap requires more than a formatted dossier—it requires understanding how INVIMA reads, interprets, and decides. Connect with Freyr to evaluate your submission’s readiness for Colombia before it reaches the authority.
